Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach

✍ Scribed by Ocean, Allyson J.; Christos, Paul; Sparano, Joseph A.; Shah, Manish A.; Yantiss, Rhonda K.; Cheng, Jonathan; Lin, Juan; Papetti, Michael; Matulich, Dan; Schnoll-Sussman, Felice; Besanceney-Webler, Christen; Xiang, Jenny; Ward, Maureen; Dilts, Kaili Temple; Keresztes, Roger; Holloway, Shannon; Chen, Eric X.; Wright, John J.; Lane, Maureen E.

• Book ID: 121551563
• Publisher: Springer US
• Year: 2014
• Tongue: English
• Weight: 165 KB
• Volume: 32
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-014-0070-0